This Is MS Multiple Sclerosis Community: Knowledge & Support

.

I think the Tovaxin idea is interesting and I look at the value of the Opexa company and I have to wonder, what happens to folks if the company runs out of money can can't keep doing the vaccine work? In a recent financial report the company's auditors said there was questionable ability of the company to continue to exist for another year. Are folks who are in the trial being made aware of this and what would happen if the company ceased to exist in the middle of the trial? Ken

_________________
My Starting Point
Understanding MS 101: Doctor Talk and People Talk<br /><br />

I would go on an immediate killing rampage.

They posted the "going concern" stuff on their webpage. I just keep my fingers crossed that they can scrounge up the money. If they are having better results than the CRAB's, I can't imagine them not coming up with the money. However, if they are not, I would imagine the company would just fold and we would be left hanging.

Do you suppose that is what this is all about.



Opexa Therapeutics Announces the Pricing of Public Offering of Shares of Common Stock and Series E Warrants

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA) today announced that it has priced a public offering of 3,500,000 shares of common stock at a price to the public of $2.00 per share and 3,500,000 Series E warrants to purchase shares of common stock exercisable at $2.00 per share at a price of $0.15 per warrant. The Company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments. The Company expects to receive approximately $7.5 million (approximately $8.7 million if the underwriter’s over-allotment option is exercised in full) in gross proceeds from the offering, which is subject to closing conditions.

MDB Capital Group LLC acted as sole managing underwriter for this offering. GunnAllen Financial, Inc. was a co-underwriter in the offering.

a bit of Opexa news of interest on the business side of things was posted recently that may raise revue.

<shortened url>

If you go to Investor Village there is a thead discussing Opexa. I posted some entries as Grundh.

The recent stock offering sure looks like it is a good deal for anyone who gets in on it at the expense of existing shareholders. I put in a call to the investment banker to participate and got a voicemail box. I get the feeling I am not gonna get a call back.

There is no money like inside money.

http://www1.investorvillage.com

When the Phase llb data is available, there will either be a lot of happy patients and investors, or a lot of patients and investors wondering what the hell happened. There is a tremendous amount riding on that document. As a non investor and a patient who has put all my eggs in this basket, I hope all you investors get filthy rich.
Think positively!!!!!
Lars

think happy thoughts.....think happy thoughts.....

Latest OPEXA stock news. posted today.

http://www.centredaily.com/business/tec ... 12171.html

Just if your curious

Any idea as to when the phase 3 part of the trial will start?

.

There is a link somewhere on here to a site called clinicaltrials.gov. Hell, that may be the link! It was posted recently but I don't remember on what thread, so maybe Google that and it should give you all the info.

.

I would be stunned if the company is blinded. Remember it's a "double blind" study, as in the lab rat and the doc are blinded, not a triple blind study where the company doesn't know what's happening until the study is over. I'm sure that as all of the data is coming in on folks it's being sorted and analyzed based on which treatment group they're in.

Mike

.